FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?
CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention.
You may also be interested in...
US FDA's drug center has been hiring more employees than it has lost over the last few months and hopes the Office of New Drugs reorganization will help retention.
Peter Stein, a leader in diabetes drug development programs, joins FDA as a new administration is about to come in; he fills one of 676 CDER vacancies.
Center for Drug Evaluation and Research's long-time director of oncology/hematology products office will continue as signatory on drug reviews even after new Cancer Moonshot-driven structure takes effect.